Events Archive

Modernising Demand Generation for HIV Prevention

With HIV prevention budgets under increasing pressure, effective and efficient communication is more vital than ever. As prevention options expand from condoms and HIV self-testing to multiple forms of PrEP tailored, impactful demand creation is essential to drive uptake and support informed choice. This session will explore how to generate demand using data-informed strategies, virtual…

From Oral PrEP to LEN: Leveling Up Prevention with the WHO–Jhpiego PrEP Provider Training Toolkit

Recording / Slides This 90-minute webinar, presented by Jhpiego and WHO, is intended for communities, providers, policy makers and advocates interested in pre-exposure prophylaxis (PrEP) for HIV prevention. The presenters will provide an overview of the recently launched WHO and Jhpiego Provider Training Toolkit on Use of Oral and Long-Acting HIV PrEP with case-based scenarios…

HIV Prevention Re-mix: Current tools, new tools, same goal

Join the UNITED! Movement and AVAC to learn more about the future of HIV prevention and what this means for young people. The webinar will cover: Prevention options currently available Long-acting PrEP products, including those currently available, available soon, and in the pipeline An update on the introduction of six month lenacapavir for PrEP Advocacy…

Will Lenacapavir be a lever or a let-down? Lessons, Resources, and Considerations for Implementation in the United States

Lenacapavir for PrEP has tremendous potential to increase access and engagement in the United States, reaching individuals who have been unable to embrace PrEP in its previous formulations. How can we ensure that our implementation lifts up, rather than lets down, individuals and communities who need this innovation most? What can we learn from past…

Supporting PrEP Access: HIV Self-Testing in Uptake and Scale-Up

Slides / Recording This webinar, co-hosted by WHO and PSI, will explore the use of HIV self-testing for PrEP initiation and continuation.

New WHO Guidance on Lenacapavir for Prevention and HIV Testing for Long-Acting PrEP

This 60-minute webinar is intended for communities, providers, policy makers and advocates for PrEP, HIV prevention and HIV testing. We will provide an overview of the key takeaways and new guidance from newly released Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. This is the first webinar in a…

PrEP Implementation: What’s worked and what are we learning

Recording / Slides Pre-exposure prophylaxis (PrEP) has emerged as a critical tool in the global HIV prevention response. Despite its proven efficacy, global uptake of oral PrEP has been slower than anticipated, falling short of UNAIDS’ 2025 targets. However, several countries have successfully scaled up oral PrEP, and in the process learnt significant lessons, many…

Town-Hall – Launch of Key Populations Long-Acting PrEP Demand Forecast

See full slide deck here Join Global Black Gay Men Connect for the official launch of the Key Populations (KP) Long-Acting PrEP Demand Forecast, developed by GBGMC and AVAC in collaboration with Avenir Health. This virtual town hall will spotlight the critical findings of the new forecast, which estimates the future need for long-acting PrEP…

Embracing Task Shifting and Innovation to Support Expanded Access to Long-Acting Injectable PrEP

Join The Choice Agenda and colleagues on June 26 for an inspiring discussion on task shifting and innovation related to improving PrEP access – injectable and otherwise. Moderator: Rupa Patel, Washington University in St. Louis Speakers: Kevin Aloysius, Legacy Community Health, Houston Megan Dieterich, Whitman-Walker Health, Washington, DC Juan Carlos Loubriel, Whitman-Walker Health, Washington, DC…

The Scientific Journey of Lenacapavir: From basic science to clinical development to impact

Join us for the compelling story of the development of lenacapavir and the critical role of US support. Wes Sundquist, from the University of Utah, will share the story of capsid inhibitor discovery; and Linda-Gail Bekker, from the Desmond Tutu HIV Foundation, will discuss the critical role of South Africa in clinical development; all of…